0001437749-19-024819.txt : 20191223 0001437749-19-024819.hdr.sgml : 20191223 20191223162956 ACCESSION NUMBER: 0001437749-19-024819 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191219 FILED AS OF DATE: 20191223 DATE AS OF CHANGE: 20191223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fratamico Arthur CENTRAL INDEX KEY: 0001598129 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55242 FILM NUMBER: 191306483 MAIL ADDRESS: STREET 1: C/O FLEXION THERAPEUTICS, INC. STREET 2: 10 MALL ROAD, SUITE 301 CITY: BURLINGTON STATE: MA ZIP: 01803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sun BioPharma, Inc. CENTRAL INDEX KEY: 0001029125 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870543922 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 712 VISTA BLVD #305 CITY: WACONIA STATE: MN ZIP: 55387 BUSINESS PHONE: 9524791196 MAIL ADDRESS: STREET 1: 712 VISTA BLVD #305 CITY: WACONIA STATE: MN ZIP: 55387 FORMER COMPANY: FORMER CONFORMED NAME: Cimarron Medical, Inc. DATE OF NAME CHANGE: 20150602 FORMER COMPANY: FORMER CONFORMED NAME: CIMARRON SOFTWARE INC DATE OF NAME CHANGE: 19961217 4 1 rdgdoc.xml FORM 4 X0306 4 2019-12-19 0001029125 Sun BioPharma, Inc. SNBP 0001598129 Fratamico Arthur 712 VISTA BLVD #305 WACONIA MN 55387 1 Stock Option (right to buy) 3.70 2019-12-19 4 A 0 6500 0 A 2029-12-19 Common Stock 6500 6500 D Stock Option (right to buy) 3.70 2019-12-19 4 A 0 26800 0 A 2029-12-19 Common Stock 26800 26800 D Scheduled to become fully exercisable the day before the annual meeting of stockholders to be held in 2020. Immediately exercisable as to 50% of the shares and scheduled to vest with respect to 25% of the shares on each of December 19, 2020 and December 19, 2021. /s/ Joshua L. Colburn 2019-12-23